Treatment of hypercalcemia related to polymethylmethacrylate injection: report of three cases.

IF 0.9 Q2 MEDICINE, GENERAL & INTERNAL
Einstein-Sao Paulo Pub Date : 2025-06-16 eCollection Date: 2025-01-01 DOI:10.31744/einstein_journal/2025RC1377
Lívia Reis de Miranda, Eduardo de Paiva Luciano, Eduarda Andrea Silva Rizzo, Marissol Fernandes Oliveira, Sheila Cavalca Cortelli, Walnei Fernandes Barbosa
{"title":"Treatment of hypercalcemia related to polymethylmethacrylate injection: report of three cases.","authors":"Lívia Reis de Miranda, Eduardo de Paiva Luciano, Eduarda Andrea Silva Rizzo, Marissol Fernandes Oliveira, Sheila Cavalca Cortelli, Walnei Fernandes Barbosa","doi":"10.31744/einstein_journal/2025RC1377","DOIUrl":null,"url":null,"abstract":"<p><p>Polymethylmethacrylate is a microsphere-based plastic used in aesthetic procedures. However, it can cause granuloma formation and severe hypercalcemia, often accompanied by renal impairment, which is a significant concern. Despite increasing reports, there is no standardized treatment approach for polymethylmethacrylate-induced hypercalcemia, and its incidence remains underreported. In this study, we present three cases of polymethylmethacrylate users who developed severe hypercalcemia that was resistant to conventional treatments, resulting in deteriorating renal function. These patients achieved symptom control with cinacalcet, a medication primarily used to treat secondary hyperparathyroidism, severe primary hyperparathyroidism, and parathyroid cancer.</p>","PeriodicalId":47359,"journal":{"name":"Einstein-Sao Paulo","volume":"23 ","pages":"eRC1377"},"PeriodicalIF":0.9000,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12176337/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Einstein-Sao Paulo","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31744/einstein_journal/2025RC1377","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Polymethylmethacrylate is a microsphere-based plastic used in aesthetic procedures. However, it can cause granuloma formation and severe hypercalcemia, often accompanied by renal impairment, which is a significant concern. Despite increasing reports, there is no standardized treatment approach for polymethylmethacrylate-induced hypercalcemia, and its incidence remains underreported. In this study, we present three cases of polymethylmethacrylate users who developed severe hypercalcemia that was resistant to conventional treatments, resulting in deteriorating renal function. These patients achieved symptom control with cinacalcet, a medication primarily used to treat secondary hyperparathyroidism, severe primary hyperparathyroidism, and parathyroid cancer.

聚甲基丙烯酸甲酯注射液所致高钙血症的治疗附3例报告。
聚甲基丙烯酸甲酯是一种微球塑料,用于美容手术。然而,它可引起肉芽肿形成和严重的高钙血症,通常伴有肾脏损害,这是一个值得关注的问题。尽管有越来越多的报道,对于聚甲基丙烯酸甲酯诱导的高钙血症尚无标准化的治疗方法,其发病率仍未得到充分报道。在本研究中,我们报告了三例聚甲基丙烯酸甲酯使用者,他们出现了严重的高钙血症,对常规治疗产生了耐药性,导致肾功能恶化。这些患者使用cinacalcet(一种主要用于治疗继发性甲状旁腺功能亢进、严重原发性甲状旁腺功能亢进和甲状旁腺癌的药物)获得了症状控制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Einstein-Sao Paulo
Einstein-Sao Paulo MEDICINE, GENERAL & INTERNAL-
CiteScore
2.00
自引率
0.00%
发文量
210
审稿时长
38 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信